Page 382 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )

366 PART 5 ■ Nonmalignant Leukocyte Disorders

HIV. S m z , α, α- m ,

m , m x β-m . R k - -

k HIV- . k - .

T m q -

m Systemic Lupus Erythematosus

HIV- . A

x m m - Etiology, Signs, and Sym ptom s

k . W z m Systemic lupus erythematosus (SLE) m

mm m HIV- - mm

m DNA m , . SLE m m -

( ) k m , m mm j ,

( ) . T , - . SLE

, , m m

- m m .

m m W . T - m m mm m

q m .

W - C m m , , m -

q m - z m mm , (j ), ( mm

- . A j ), m ( -

. A ) . D

SLE- k m . T m

z , m , z . I

. , , ,

I z

. m m .

T D m q

m m mm m x

m. T k . A k

m q , m

mm m x , - m . A

HIV- – ,

. , m .

Antibodies to HIV-1 Laboratory Data

A HIV- x - T SLE m . T

m k m - , , LE ,

. B , m - , , ,

- m m .

.

I HIV LE Cell Preparation

% % , T LE

CMV, EBV, A B, . gondii . A LE m m

mm ( - ) m x m

. C , m m m . T

HIV k m m .

. I ,

m - Antibody Tests

, m . I A DNA mm m

m m , - m . ANA

. - , SLE

m LE

. NA , , q -

. ANA m
Other Im m une Changes .

A mm . T - m

mm m (DNA RNA) ( )